𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Deramciclane in the treatment of patients with generalised anxiety disorder: A randomised, double-blind, placebo-controlled, dose-finding study

✍ Scribed by H. Naukkarinen

Book ID
119575507
Publisher
Elsevier Science
Year
2001
Tongue
English
Weight
275 KB
Volume
11
Category
Article
ISSN
0924-977X

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Escitalopram in the treatment of general
Escitalopram in the treatment of generalized anxiety disorder: Double-blind, placebo controlled, flexible-dose study
✍ Jonathan R.T. Davidson; Anjana Bose; Andrew Korotzer; Hongjie Zheng πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 128 KB πŸ‘ 2 views

Escitalopram has been shown in clinical trials to improve anxiety symptoms associated with depression, panic disorder, and social anxiety disorder. This study was designed to evaluate the efficacy and tolerability of escitalopram in the treatment of generalized anxiety disorder (GAD). Outpatients (1

Alprazolam in the treatment of generaliz
Alprazolam in the treatment of generalized anxiety and panic disorders: A double-blind placebo-controlled study
✍ G. Chouinard; L. Annable; R. Fontaine; L. Solyom πŸ“‚ Article πŸ“… 1982 πŸ› Springer 🌐 English βš– 472 KB

In a double-blind controlled study lasting 8 weeks, 50 anxious psychoneurotic outpatients with a primary diagnosis of generalized anxiety or panic disorder were randomly assigned to alprazolam (n = 30), a new benzodiazepine, or placebo (n = 20), after a washout period of 1 week. Alprazolam at dosage